《大行报告》瑞银微升瑞声(02018.HK)目标价至32.5元 维持「沽售」评级
瑞银发表研究报告,下调瑞声科技(02018.HK)2020至2022年各年每股盈测分别29%、19%及18%,以反映盈利能力转弱,维持「沽售」评级,目标价由32元微升至32.5元。即使部分投资者对今年手机镜头销量增长及潜在玻塑混合镜头(WLG)潜在采用感乐观,但由於中低端手机镜头价格竞争加剧,该行维持其盈利能力保守看法。
报告称,瑞声正在中端手机领域扩大声学及触碰马达产品,以抵销在iPhone供应链市占减少及销售均价下跌的影响,但Android手机升级速度放缓料限制增长空间。即使现估值仅相当於今年预测市盈率22倍,但相信部分投资者对瑞声今年潜在转势仍过分乐观,特别是光学板块。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.